NurkS., KorenS., RhieA., et al.The complete sequence of a human genome. Science, 376(6588):44–53 (2022).
3.
StarkZ., DolmanL., ManolioT., et al.Integrating genomics into healthcare: a global responsibility. Am J Hum Genet, 104(1):13–20 (2019).
4.
PhillipsK.A., DouglasM.P., WordsworthS., et al.Availability and funding of clinical genomic sequencing globally. BMJ Glob Health, 6(2):e004415 (2021).
5.
PhillipsK.A., DouglasM.P., WordsworthS., et al.Expanding use of clinical genome sequencing and the need for more data on implementation. JAMA, 324(20):2029–2030 (2020).
6.
NICUSeq Study Group. Effect of whole-genome sequencing on the clinical management of acutely ill infants with suspected genetic disease: a randomized clinical trial. JAMA Pediatr, 175(12):1218–1226 (2021).
7.
The 100,000 Genomes Project Pilot Investigators. 100,000 Genomes Pilot on Rare-Disease Diagnosis in Health Care — Preliminary Report. N Engl J Med, 385:1868–1880 (2021).
OECD/European Observatory on Health Systems and Policies (2021), Estonia: Country Health Profile 2021, State of Health in the EU, OECD Publishing, Paris/Europe an Observatory on Health Systems and Policies, Brussels.
11.
VrijenhoekT., TonissonN., KääriäinenH. et al.Clinical genetics in transition—a com parison of genetic services in Estonia, Finland, and the Netherlands. J Community Genet, 12(2):277–290 (2021).
SheinsonD.M., WongW.B., MeyerC.S., et al.Trends in use of next-generation sequencing in patients with solid tumors by race and ethnicity after implementation of the Medicare National Coverage Determination. JAMA Netw Open, 4(12): e2138219 (2021).
14.
Austin-TseC.A., JobanoputraV., PerryD.L., et al.Best practices for the interpreta tion and reporting of clinical whole genome sequencing. NPJ Genom Med, 7, article 27 (2022).
15.
WicklandD.P., ShermanM.E., RadiskyD.C., et al.Lower exome sequencing cover age of ancestrally African patients in The Cancer Genome Atlas. J Natl Cancer Inst, 114(8):1192–1199 (2022).